0
ARTICLE |

Hyperkalemia Associated with the Myeloproliferative Disorder

RALPH M. MYERSON, M.D.; ABRAHAM M. FRUMIN, M.D.
Arch Intern Med. 1960;106(4):479-482. doi:10.1001/archinte.1960.03820040017003.
Text Size: A A A
Published online

Elevated serum potassium levels unassociated with manifestations of hyperkalemia have been observed in patients with thrombocythemia associated with the myeloproliferative disorder.1-3 Studies indicate that potassium released from platelets during the process of blood coagulation is responsible, since serum prepared from platelet-free plasma has a normal potassium concentration. "Spurious hyperkalemia" has been suggested as a term for this syndrome.3 We wish to reemphasize these findings with additional observations.

Results and Comment  Table 1 lists the clinical and laboratory data in a group of patients with elevations of leukocytes, erythrocytes, and platelets alone or in various combinations. Significant elevations of serum potassium levels above the normal level of 5 mEq. per liter were noted in Patients 1, 4, 5, 6, 7, 8, 9, and 14. In each of these patients there was a significant elevation of the platelet count. In the absence of thrombocythemia, elevations of the leukocyte or erythrocyte

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 29

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs